Apeiron Capital Investment Corp. announces the separate trading of its Class A ordinary shares and warrants, effective December 30, 2021
Boston, MA, December 29, 2021 (GLOBE NEWSWIRE) – Apeiron Capital Investment Corp. (NYSE: APN U) (the “Company”) announced today that effective December 30, 2021, holders of units sold in the initial public offering may elect to separately trade the Class A ordinary shares of the Company. and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will be traded. The Class A Common Shares and the Separate Warrants will trade on the New York Stock Exchange under the symbols “APN” and “APN W”, respectively. Non-segregated Units will continue to trade on the New York Stock Exchange under the symbol “APN U”.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company, and there will be no sale of such securities in any state or jurisdiction in which such an offer, solicitation or sale would be illegal prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Apeiron Capital Investment Corp.
The Company is a blank check company incorporated for the purpose of effecting a merger, a capital stock exchange, an acquisition of assets, a purchase of shares, a reorganization or a similar business combination with one or more companies. . While the Company may pursue an initial goal of business combination at any stage of its business development or in any industry or sector, it intends to focus its research on companies in the financial technology, media, gaming and financial services (“FTMG”) fields and in the wealth advisory and asset management sectors. The Company is headed by its CEO, Dr. Joel Shulman.
This press release may include, and oral statements made from time to time by representatives of the Company may include, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and the Section 21E of the Securities Act of 1933. Foreign Exchange Act of 1934, as amended. Statements regarding possible business combinations and their financing, and related matters, and all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, ” could “,” could “,” could “,” plan “,” possible “,” potential “,” foresee “,” project “,” should “,” would “and similar expressions, with respect to us or our management team, identify forward-looking statements. These forward-looking statements are based on the beliefs of the management, as well as on the assumptions made by the management of the Company and on the information currently available to the latter. Actual results could differ materially from those contemplated by forward-looking statements due to certain factors detailed in documents filed by the Company with the Securities and Exchange Commission (“SEC”). All subsequent written or oral forward-looking statements attributable to us or to persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set out in the Risk Factors section of the Company’s registration statement and prospectus for the initial public offering. of the Company filed with the SEC. The Company assumes no obligation to update these statements for revisions or changes after the date of this posting, except as required by law.
Dr Joël Shulman
Chief executive officer